Effect of Rituximab in Primary Central Nervous System Lymphoma - results of the Randomized Phase III HOVON 105/ALLG NHL 24 Study

被引：0
|
作者：
Bromberg, Jacoline
Issa, Samar
Bukanina, Katerina
Minnema, Monique C.
Seute, Tatjana
Durian, Marc
Cull, Gavin
Schouten, Harry C.
Stevens, Wendy B.
Zijlstra, Josee
Baars, Johanna W.
Nijland, Marcel
Mason, Kylie
Beeker, Aart
van den Bent, Martin
de Jong, Daphne
Gonzales, Michael Anthony
Doorduijn, Jeanette K.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
582
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Primary central nervous system lymphoma: Results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy
    Pels, H
    Schmidt-Wolf, IGH
    Glasmacher, A
    Schulz, H
    Engert, A
    Diehl, V
    Zellner, A
    Schackert, G
    Reichmann, H
    Kroschinsky, F
    Vogt-Schaden, M
    Egerer, G
    Bode, U
    Schaller, C
    Deckert, M
    Fimmers, R
    Helmstaedter, C
    Atasoy, A
    Klockgether, T
    Schlegel, U
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) : 4489 - 4495
  • [42] CSF RITUXIMAB CONCENTRATION AND EFFECT AFTER INTRATHECAL ADMINISTRATION OF RITUXIMAB IN CNS RELAPSEOF SYSTEMIC LYMPHOMA - RESULTS FROM THE PROSPECTIVE PHASE II HOVON 80 STUDY
    Bromberg, Jacoline
    Schouten, Harry
    Schaafsma, Ron
    Baars, Joke
    Brandsma, Dieta
    Lugtenburg, Petronella
    van Montfort, Cees
    van den Bent, Martin
    Doorduijn, Jeanette
    NEURO-ONCOLOGY, 2013, 15 : 102 - 102
  • [43] Role of rituximab in treatment of patients with primary central nervous system lymphoma: a retrospective analysis of the Czech lymphoma study group registry
    Mocikova, Heidi
    Pytlik, Robert
    Sykorova, Alice
    Janikova, Andrea
    Prochazka, Vit
    Vokurka, Samuel
    Berkova, Adela
    Belada, David
    Campr, Vit
    Buresova, Lucie
    Trneny, Marek
    LEUKEMIA & LYMPHOMA, 2016, 57 (12) : 2777 - 2783
  • [44] A study of primary central nervous system lymphoma in northern India
    Powari, M
    Radotra, B
    Das, A
    Banerjee, A
    SURGICAL NEUROLOGY, 2002, 57 (02): : 113 - 116
  • [45] Primary lymphoma of the central nervous system: a clinicopathologic study.
    Taniguchi E.
    Brain Tumor Pathology, 2001, 18 (2) : 101 - 108
  • [46] Study on primary central nervous system lymphoma in pediatric patients
    Li, Xiang
    Gong, Jian
    CHILDS NERVOUS SYSTEM, 2023, 39 (08) : 2037 - 2043
  • [47] Study on primary central nervous system lymphoma in pediatric patients
    Xiang Li
    Jian Gong
    Child's Nervous System, 2023, 39 : 2037 - 2043
  • [48] A Phase II Study of the Efficacy and Safety of the Srmt ( Sintilimab, Rituximab, Methotrexate, and Temozolomide) Regimen in Newly Diagnosed Primary Central Nervous System Lymphoma
    Zeng, Zhiyong
    Yang, Apeng
    Lin, Yuanxiang
    Chen, Junmin
    BLOOD, 2023, 142
  • [49] Primary central nervous system lymphoma treated with rituximab plus temozolomide in a second line schedule
    M. Santisteban
    Y. Nieto
    S. De la Cruz
    J. Aristu
    J. L. Zubieta
    O. Fernández Hidalgo
    Clinical and Translational Oncology, 2007, 9 : 465 - 467
  • [50] Pemetrexed plus rituximab as second-line treatment for primary central nervous system lymphoma
    Hai-Tao Zhao
    Jing Chen
    Sheng-bin Shi
    Jing Tian
    Rong-Jie Tao
    Medical Oncology, 2015, 32
12345